Skip to main content
Log in

Cancer-retina antigens — A new group of tumor antigens

  • Review
  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

Some photoreceptor proteins normally specific for the eye retina are aberrantly expressed in malignant tumors. These proteins include recoverin, visual rhodopsin, transducin, cGMP-phosphodiesterase 6 (PDE 6), cGMP-dependent cationic channels, guanylyl cyclase 1, rhodopsin kinase, and arrestin. By analogy with cancer-testis antigens, these photoreceptor proteins form the group of cancer-retina antigens. It is shown that an aberrant demethylation of the promoter region of recoverin is involved in the aberrant expression of this protein. The cascade Wnt5a → Frizzled-2 → transducin → PDE 6 is shown to function in skin melanoma cells, and this suggests that these cancer-retina antigens can play a functional role. The events accompanying the signal transduction in this cascade, including those involving calcium ions and cGMP-dependent protein kinase (protein kinase G), are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADC:

5-aza-2′-deoxycytidine

CAR:

cancer-associated retinopathy

MAR:

melanoma-associated retinopathy

NSCLC:

non-small cell lung carcinoma

PDE 6:

cGMP-phosphodiesterase 6

SCLC:

small cell lung carcinoma

References

  1. Are, C., Rajaram, S., Are, M., Raj, H., Anderson, B. O., Chaluvarya Swamy, R., Vijayakumar, M., Song, T., Pandey, M., Edney, J. A., and Cazap, E. L. (2013) A review of global cancer burden: trends, challenges, strategies, and a role for surgeons, J. Surg. Oncol., 107, 221–226.

    Article  PubMed  Google Scholar 

  2. Kulkarni, P., Shiraishi, T., Rajagopalan, K., Kim, R., Mooney, S. M., and Getzenberg, R. H. (2012) Cancer/testis antigens and urological malignancies, Nat. Rev. Urol., 9, 386–396.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Ries, L. A. G., Horner, M.-J., and Young, J. L. (2007) Introduction, in SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics (Ries, L. A. G., Young, J. L., Keel, G. E., Eisner, M. P., Lin, Y. D., and Horner, M.- J., eds.) National Cancer Institute, SEER Program, NIH, Bethesda, pp. 1–6.

    Google Scholar 

  4. Graziano, D. F., and Finn, O. J. (2005) Tumor antigens and tumor antigen discovery, Cancer Treat. Res., 123, 89–111.

    Article  CAS  PubMed  Google Scholar 

  5. Aly, H. A. (2012) Cancer therapy and vaccination, J. Immunol. Methods, 382, 1–23.

    Article  CAS  PubMed  Google Scholar 

  6. National Cancer Institute, Fact Sheet (2011) Tumor-markers; http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers.

    Google Scholar 

  7. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, 254, 1643–1647.

    Article  PubMed  Google Scholar 

  8. Old, L. J. (2001) Cancer/testis (CT) antigens — a new link between gametogenesis and cancer, Cancer Immun., 1, 1.

    CAS  PubMed  Google Scholar 

  9. De Smet, C., and Loriot, A. (2013) DNA hypomethylation and activation of germline-specific genes in cancer, Adv. Exp. Med. Biol., 754, 149–166.

    Article  PubMed  Google Scholar 

  10. Philippov, P. P., Senin, I. I., and Koch, K.-W. (2006) Recoverin: a calcium-dependent regulator of the visual transduction, in Neuronal Calcium Sensor Proteins (Philippov, P., and Koch, K.-W., eds.) Nova Science Publishers, N. Y., pp. 139–151.

    Google Scholar 

  11. Bazhin, A. V., Schadendorf, D., Philippov, P. P., and Eichmuller, S. B. (2007) Recoverin as a cancer-retina antigen, Cancer Immunol. Immunother., 56, 110–116.

    Article  CAS  PubMed  Google Scholar 

  12. Bazhin, A. V., Schadendorf, D., Willner, N., De Smet, Ch., Henzelmann, A., Tikhomirova, N. K., Umansky, V., Philippov, P. P., and Eichmuller, S. B. (2007) Photoreceptor proteins as cancer-retina antigens, Int. J. Cancer, 120, 1268–1276.

    CAS  PubMed  Google Scholar 

  13. Dizhur, A. M., Nekrasova, E. R., and Filippov, P. P. (1991) New 26-kDa protein specific for photoreceptor cells, capable of binding with immobilized delipidated rhodopsin, Biokhimiya, 56, 225–229.

    CAS  Google Scholar 

  14. Dizhoor, A. M., Ray, S., Kumar S., Niemi, G., Spencer, M., Broley, D., Walsh, K. A., Philipov, P. P., Hurley, J. B., and Stryer, L. (1991) Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase, Science, 251, 915–918.

    Article  CAS  PubMed  Google Scholar 

  15. Polans, A. S., Buczylko, J., Crabb, J., and Palczewski, K. (1991) A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy, J. Cell Biol., 112, 981–989.

    Article  CAS  PubMed  Google Scholar 

  16. Adamus, G. (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy, Autoimmun. Rev., 8, 410–414.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Adamus, G. (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy, Autoimmun. Rev., 2, 63–68.

    Article  CAS  PubMed  Google Scholar 

  18. Robson, J. G., and Frishman, L. J. (2013) The rod-driven α-wave of the dark-adapted mammalian electroretinogram, Prog. Retin. Eye Res., 39, 1–22.

    Article  PubMed  Google Scholar 

  19. Jacobson, D. M., Thirkill, C. E., and Tipping, S. J. (1990) A clinical triad to diagnose paraneoplastic retinopathy, Ann. Neurol., 28, 162–167.

    Article  CAS  PubMed  Google Scholar 

  20. Chan, J. W. (2003) Paraneoplastic retinopathies and optic neuropathies, Surv. Ophthalmol., 48, 12–38.

    Article  PubMed  Google Scholar 

  21. Grunwald, G. B., Kornguth, S. E., Towfighi, J., Sassani, J., Simmonds, M. A., Housman, C. M., and Papadopoulos, N. (1987) Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells, Cancer, 60, 780–786.

    Article  CAS  PubMed  Google Scholar 

  22. Kornguth, S. E., Klein, R., Appen, R., and Choate, J. (1982) Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung, Cancer, 50, 1289–1293.

    Article  CAS  PubMed  Google Scholar 

  23. Kornguth, S. E., Kalinke, T., Grunwald, G. B., Schutta, H., and Dahl, D. (1986) Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome, Cancer Res., 46, 2588–2595.

    CAS  PubMed  Google Scholar 

  24. Thirkill, C. E., Roth, A. M., and Keltner, J. L. (1987) Cancer-associated retinopathy, Arch. Ophthalmol., 105, 372–375.

    Article  CAS  PubMed  Google Scholar 

  25. Polans, A. S., Witkowska, D., Haley, T. L., Amundson, D., Baizer, L., and Adamus, G. (1995) Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy, Proc. Natl. Acad. Sci. USA, 92, 9176–9180.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Adamus, G., Amundson, D., and MacKay, P. G. (1998) Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy, Arch. Ophthalmol., 116, 251–253.

    CAS  PubMed  Google Scholar 

  27. Klingele, T. G., Burde, R. M., Rappazzo, J. A., Isserman, M. J., Burgess, D., and Kantor, O. (1984) Paraneoplastic retinopathy, J. Clin. Neuroophthalmol., 4, 239–245.

    CAS  PubMed  Google Scholar 

  28. Eltabbakh, G. H., and Hoogereland, D. L. (1995) Paraneoplastic retinopathy associated with uterine sarcoma, Gynecol. Oncol., 58, 120–123.

    Article  CAS  PubMed  Google Scholar 

  29. Matsubara, S., Yamaji, Y., Fujita, T., Kanayama, T., Yamadori, I., Sato, M., Fujita, J., Shiotani, T., and Takahara, J. (1996) Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity, Lung Cancer, 14, 265–271.

    Article  CAS  PubMed  Google Scholar 

  30. Thirkill, C. E., Keltner, J. L., Tyler, N. K., and Roth, A. M. (1993) Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy, Arch. Ophthalmol., 111, 931–937.

    Article  CAS  PubMed  Google Scholar 

  31. Salgia, R., Hedges, T. R., Rizk, M., Reimerm, R. H., and Skarin, A. T. (1998) Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma, Lung Cancer, 22, 149–152.

    Article  CAS  PubMed  Google Scholar 

  32. Bazhin, A. V., Savchenko, M. S., Shifrina, O. N., Demoura, S. A., Chikina, S. Yu., Jaques, G., Kogan, E. A., Chuchalin, A. G., and Philippov, P. P. (2004) Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors, Lung Cancer, 44, 193–198.

    Article  PubMed  Google Scholar 

  33. Maeda, A., Ohguro, H., Maeda, T., Wada, I., Sato, N., Kuroki, Y., and Nakagawa, T. (2000) Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines, Cancer Res., 60, 1914–1920.

    CAS  PubMed  Google Scholar 

  34. Farber, D. B., Danciger, J. S., and Organisciak, D. T. (1991) Levels of mRNA encoding proteins of the cGMP cascade as a function of light environment, Exp. Eye Res., 53, 781–786.

    Article  CAS  PubMed  Google Scholar 

  35. McGinnis, J. F., Whelan, J. P., and Donoso, L. A. (1992) Transient, cyclic changes in mouse visual cell gene products during the light-dark cycle, J. Neurosci. Res., 31, 584–590.

    Article  CAS  PubMed  Google Scholar 

  36. Wiechmann, A. F., and Sinacola, M. K. (1997) Diurnal expression of recoverin in the rat retina, Brain Res. Mol. Brain Res., 45, 321–324.

    CAS  PubMed  Google Scholar 

  37. Bazhin, A. V., Schadendorf, D., Owen, R. W., Zernii, E. Yu., Philippov, P. P., and Eichmuller, S. B. (2008) Visible light modulates the expression of cancer-retina antigens, Mol. Cancer Res., 6, 110–118.

    Article  CAS  PubMed  Google Scholar 

  38. Milam, A. H., Saari, J. C., Jacobson, S. G., Lubinski, W. P., Feun, L. G., and Alexander, K. R. (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy, Invest. Ophthalmol. Vis. Sci., 34, 91–100.

    CAS  PubMed  Google Scholar 

  39. Potter, M. J., Thirkill, C. E., Dam, O. M., Lee, A. S., and Milam, A. H. (1999) Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy, Ophthalmology, 106, 2121–2125.

    Article  CAS  PubMed  Google Scholar 

  40. Bazhin, A., Dalke, C., Willner, N., Abschutz, O., Wildberger, H., Philippov, P., Dummer, R., Graw, J., Hrabe de Angelis, M., Schadendorf, D., Umansky, V., and Eichmbller, S. (2009) Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy, Int. J. Cancer, 124, 140–149.

    CAS  PubMed  Google Scholar 

  41. Potter, M. J., Adamus, G., Szabo, S. M., Lee, R., Mohaseb, K., and Behn, D. (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy, Am. J. Ophthalmol., 134, 128–130.

    Article  PubMed  Google Scholar 

  42. Pfohler, C., Preuss, K. D., Tilgen, W., Stark, A., Regitz, E., Fadle, N., and Pfreundschuh, M. (2007) Mitofilin and titin as target antigens in melanoma-associated retinopathy, Int. J. Cancer, 120, 788–795.

    PubMed  Google Scholar 

  43. Matsuo, S., Ohguro, H., Ohguro, I., and Nakazawa, M. (2010) Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells, Ophthalmic Res., 43, 139–144.

    Article  CAS  PubMed  Google Scholar 

  44. Esteller, M. (2007) Epigenetic gene silencing in cancer: the DNA hypermethylome, Hum. Mol. Genet., 16, R50–R59.

    Article  CAS  PubMed  Google Scholar 

  45. Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer, Cell, 128, 683–692.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Gronbeek, K., Hother, C., and Jones, P. A. (2007) Epigenetic changes in cancer, APMIS, 115, 1039–1059.

    Article  Google Scholar 

  47. Li, Y., Liu, Z. L., Zhang, K. L., Chen, X. Y., Kong, Q. Y., Wu, M. L., Sun, Y., Liu, J., and Li, H. (2009) Methylation-associated silencing of S100A4 expression in human epidermal cancers, Exp. Dermatol., 18, 842–848.

    Article  CAS  PubMed  Google Scholar 

  48. De Smet, C., De Backer, O., Faraoni, F., Lurquin, C., Brasseur, F., and Boon, T. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation, Proc. Natl. Acad. Sci. USA, 93, 7149–7153.

    Article  PubMed Central  PubMed  Google Scholar 

  49. De Smet, C., Lurquin, C., Lethe, B., Martelange, V., and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter, Mol. Cell. Biol., 19, 7327–7335.

    PubMed Central  PubMed  Google Scholar 

  50. Bazhin, A. V., De Smet, Ch., Golovastova, M. O., Schmidt, J., and Philippov, P. P. (2010) Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells, Exp. Dermatol., 19, 1023–1025.

    Article  CAS  PubMed  Google Scholar 

  51. McGinnis, J. F., Austin, B., Klisak, I., Heinzmann, C., Kojis, T., Sparkes, R. S., Bateman, J. B., and Lerious, V. (1995) Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1, J. Neurosci. Res., 40, 165–168.

    Article  CAS  PubMed  Google Scholar 

  52. Murakami, A., Yajima, T., and Inana, G. (1992) Isolation of human retinal genes: recoverin cDNA and gene, Biochem. Biophys. Res. Commun., 187, 234–244.

    Article  CAS  PubMed  Google Scholar 

  53. Miyagawa, Y., Ohguro, H., Odagiri, H., Maruyama, I., Maeda, T., Maeda, A., Sasaki, M., and Nakazawa, M. (2003) Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines, Biochem. Biophys. Res. Commun., 300, 669–673.

    Article  CAS  PubMed  Google Scholar 

  54. Bazhin, A. V., Tambora, V., Dikova, D., Philippov, P. P., Schadendorf, D., and Eichmuller, S. B. (2010) cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells, Cell. Mol. Life Sci., 67, 817–828.

    Article  CAS  PubMed  Google Scholar 

  55. Wang, H. Y., and Malbon, C. C. (2004) Wnt-Frizzled signaling to G-protein-coupled effectors, Cell. Mol. Life Sci., 61, 69–75.

    Article  CAS  PubMed  Google Scholar 

  56. Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J., and Nusse, R. (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor, Nature, 382, 225–230.

    Article  CAS  PubMed  Google Scholar 

  57. Miller, J. R. (2002) The Wnts, Genome Biol., 3, 1–15.

    Google Scholar 

  58. Francis, S. H., Busch, J. L., and Corbin, J. D. (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action, Pharmacol. Rev., 62, 525–563.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Karakhanova, S., Golovastova, M., Philippov, P. P., Werner, J., and Bazhin, A. V. (2014) Interlude of cGMP and cGMP/protein kinase G type I in pancreatic adenocarcinoma cells, Pancreas, 43, 784–794.

    Article  CAS  PubMed  Google Scholar 

  60. Fraser, M., Chan, S. L., Chan, S. S., Fiscus, R. R., and Tsang, B. K. (2006) Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells, Oncogene, 25, 2203–2212.

    Article  CAS  PubMed  Google Scholar 

  61. Leung, E. L., Wong, J. C., Johlfs, M. G., Tsang, B. K., and Fiscus, R. R. (2010) Protein kinase G type Iα activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation, Mol. Cancer Res., 8, 578–591.

    Article  CAS  PubMed  Google Scholar 

  62. Ma, L., and Wang, H. Y. (2007) Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway, J. Biol. Chem., 282, 28980–28990.

    Article  CAS  PubMed  Google Scholar 

  63. Konig, A., Fernandez-Zapico, M. E., and Ellenrieder, V. (2010) Primers on molecular pathways — the NFAT transcription pathway in pancreatic cancer, Pancreatology, 10, 416–422.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. O. Golovastova.

Additional information

Original Russian Text © M. O. Golovastova A. V. Bazhin, P. P. Philippov, 2014, published in Biokhimiya, 2014, Vol. 79, No. 8, pp. 923–931.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golovastova, M.O., Bazhin, A.V. & Philippov, P.P. Cancer-retina antigens — A new group of tumor antigens. Biochemistry Moscow 79, 733–739 (2014). https://doi.org/10.1134/S000629791408001X

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S000629791408001X

Key words

Navigation